As of June 30, 2026, Changmao Biochemical Engineering Co. Ltd. Class H carries a market capitalization of 153.84M, placing it among publicly traded companies globally. Its enterprise value stands at 672.27M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 153.84M |
| Enterprise Value | 672.27M |
As of June 30, 2026, Changmao Biochemical Engineering Co. Ltd. Class H has 529.70M shares outstanding.
| Shares Outstanding | 529.70M |
These figures are as of June 30, 2026.
| PB Ratio | 0.26 |
| P/TBV Ratio | 0.26 |
As of June 30, 2026, Changmao Biochemical Engineering Co. Ltd. Class H maintains a current ratio of 0.44, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.44 |
| Quick Ratio | 0.08 |
| Debt / Equity | 95.63 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 518.00 |
As of the close on November 17, 2026, Changmao Biochemical Engineering Co. Ltd. Class H's stock has declined approximately 30.77% over the past 52 weeks. The 50-day moving average sits at 0.26, while the 200-day moving average is 0.30.
| 52-Week Price Change | -30.77% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.30 |
As of June 30, 2026, Changmao Biochemical Engineering Co. Ltd. Class H holds 45.68M in cash and equivalents against 564.90M in total debt, resulting in a net debt position of 521.35M. Total book value stands at 591.47M, with working capital of -333.68M providing operational flexibility.
| Cash & Cash Equivalents | 45.68M |
| Total Debt | 564.90M |
| Net Debt | 521.35M |
| Equity (Book Value) | 591.47M |
| Book Value Per Share | 1.12 |
| Working Capital | -333.68M |
Already premium?